Publications
- New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting2008 | First Faculty of Medicine
- Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting2008 | First Faculty of Medicine
- Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice2007 | First Faculty of Medicine
- Properties of HMPA copolymer - doxorubicin conjugates with pH-controlled activation: Effect of polymer chain modification2006 | First Faculty of Medicine
- Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity2005 | First Faculty of Medicine
- Antibody-targeted HPMA copolymer-bound doxorubicin conjugates can completely cure tumor-bearing mice and establish long-term immunological memory against the original tumorPublication without faculty affiliation
- Anti-tumour resistance in mice treated with HPMA-based doxorubicin conjugate containing human intravenous immunoglobulin +1Publication without faculty affiliation
- HPMA-based doxorubicin conjugate containing human intravenous immunoglobulins shows anticancer effect and protection of immunityPublication without faculty affiliation
- HPMA copolymer-doxorubicin conjugates with hydrolytically controlled drug releasePublication without faculty affiliation
- Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin inuduces anti-tumor immunityPublication without faculty affiliation
Loading network view...